Abstract:To control graft-versus-host disease (GVHD) following allogeneic hematopoietic stem cell (HSC) transplantation while maintaining the graft antileukemic effects of donor T cells, a suicide gene encoding the herpes simplex virus thymidine kinase (HSV-TK) enzyme was introduced ex vivo via a retroviral vector into donor T cells. Although previous clinical trials showed that it was an efficient tool for controlling GVHD, the gene transduction process of donor T lymphocytes may influence the immunocompetence of the T cells. In the current study, we investigated the impact that the gene manipulation in vitro had on the phenotype and functionality of human donor T lymphocytes. We engineered human T lymphocytes with HSV-TK and puromycin resistance gene with a retrovirus vector and analyzed the phenotype change of gene modified cells with flowcytometry. The secretion of gamma-interferon and interleukin-4 of T lymphocyte were detected with enzyme-linked immunospot(ELIPOT)assays. We also analyzed the lytic activity of T cells against allogeneic targets. The result showed that the number of TK gene transduced T lymphocyte was sufficient for clinical use. There was an inversion of the CD4+/CD8+ ratio in the gene modified T cell (GMC) compared with the fresh peripheral blood lymphocytes (PBLs). In addition, the GMCs showed a higher expression of HLA-DR and had more antigen-experienced cells than did the PBLs. In ELIPOT assays, significantly less gamma-interferon secretion by GMCs was observed compared to PBLs (50 vs. 115 spots/well-3×104cells, p<0.05). The results also showed that IL-4-secreting cell frequencies was similar in GMCs and in PBLs (19.3 vs. 20.3 spots/well-3×104cells, p>0.05). After stimulated by allogeneic PBMCs, the GMCs effectors showed a significant reduction in lytic activity against allogeneic targets in contrast with PBL. In conclusion, HSV-TK gene transduction and selection procedure can change the phenotype and functions of human T lymphocyte. The gene modified T lymphocytes still showed biological activities although lower than those of PBLs.

Effect of CCR5Delta32 Gene Expression in Human Peripheral Blood Mononuclear cells(PBMC)on Proliferation Function of the PBMC

The Serum Levels and Roles of Regulated Upon Activation Normal T Cell Expressed and Secreted and Monocyte Chemoattractant Protein-1 in Human Immunodeficiency Virus-1 Infected Patients

Receptor Expression and Responsiveness of Human Peripheral Blood Mononuclear Cells to a Human Cytomegalovirus Encoded CC Chemokine

Rerovirus Mediated Hsv-Tk Gene Transfer Can Influence The Function Of Human T-Lymphocyte

Lentivirus-Mediated Gene Transfer and Expression in Established Human Tumor Antigen-Specific Cytotoxic T Cells and Primary Unstimulated T Cells

Specific T-cell Receptor Gene Transfer Enhances Immune Response: A Potential Therapeutic Strategy for the Control of Human Cytomegalovirus Infection in Immunocompromised Patients

Regulation of Human Immunodeficiency Virus Type 1 Infection, Β-Chemokine Production, and CCR5 Expression in CD40L-Stimulated Macrophages: Immune Control of Viral Entry

Recombinant HCMV UL128 Expression and Functional Identification of PBMC-attracting Activity in Vitro

Effects of Lentiviral Vector-Mediated RNAi on Expression of CCR5 in CD34 + Cells in Peripheral Blood of Mice

Induced recovery of defective membrane expression of a CC chemokine receptor 5 mutant by phytohemagglutinin

Therapeutic Effect of RANTES–KDEL on Inhibition of HIV-1 in CD34+ Human Hematopoietic Stem Cells (Hhsc)

Establishment and characterization of CHO cell line stably expressing human CCR5 gene

Studies on Establishment of Co-expression System and Function of Human Complement Regulatory Proteins MCP and CD59

Effect of supernatants from cord blood mononuclear cells and peripheral blood mononuclear cells on infection of HIV-1 in vitro

Up-Regulation of CCR5 and CXCR4 Expression on Human Monocytes by Interferon Gamma

Talens-Mediated Homozygous Ccr5 Delta 32 Mutations Endow Cd4(+) U87 Cells With Resistance Against Hiv-1 Infection

Construction and Characterization of Plasmid Expressing Human CCR5 Gene in Eukaryotes

In Vitro Immunological Effects of Blocking CCR5 on T Cells

Studies on co-expression and function of human complement regulatory proteins MCP and CD59 in stably transfected NIH3T3 cells

High Level Expression, Purification and Characterization of Recombinant CCR5 As a Vaccine Candidate Against HIV.

Experimental study on gene transfer into K562 cells mediated by retroviral vector